Suppr超能文献

MJ347 - 81F4 A和B,来自拟无枝酸菌属的新型抗生素:分类特征、发酵及抗菌活性

MJ347-81F4 A & B, novel antibiotics from Amycolatopsis sp.: taxonomic characteristics, fermentation, and antimicrobial activity.

作者信息

Sasaki T, Otani T, Matsumoto H, Unemi N, Hamada M, Takeuchi T, Hori M

机构信息

Taiho Pharmaceutical Co., Ltd., Tokushima Research Center, Japan.

出版信息

J Antibiot (Tokyo). 1998 Aug;51(8):715-21. doi: 10.7164/antibiotics.51.715.

Abstract

Strain MJ347-81F4 has been found to produce two new cyclic thiazolyl peptide antibiotics, components A and B. Taxonomic studies including morphological and physiological characteristics and chemical analysis of whole cells of the producing strain revealed this microorganism to belong to genus Amycolatopsis, and so we designated the strain Amycolatopsis sp. MJ347-81F4. After 10 to 12 days of fermentation, most of the antibacterial activity was present mainly in the mycelial cake and reached its maximum level. In comparison with reference compounds, A as the major component showed excellent in vitro activity against gram-positive bacteria including highly methicillin-resistant Staphylococcus aureus (MRSA) and Enterococcus faecalis with MICs in the range of concentration of 0.006 to to approximately 0.1 microg/ml. The results on the antimicrobial activity against thiazolyl peptide-resistant mutants of Bacillus subtilis NRRL B-558 indicated that the possible molecular target of MJ347-81F4 component A might be the 50S subunits of the ribosome, the inactivation of which would inhibit protein synthesis.

摘要

菌株MJ347 - 81F4已被发现能产生两种新的环状噻唑基肽抗生素,即组分A和组分B。包括形态学和生理学特征以及产生菌全细胞化学分析在内的分类学研究表明,该微生物属于拟无枝酸菌属,因此我们将该菌株命名为拟无枝酸菌属MJ347 - 81F4。发酵10至12天后,大部分抗菌活性主要存在于菌丝饼中,并达到最高水平。与参考化合物相比,作为主要成分的A对革兰氏阳性菌具有优异的体外活性,包括高度耐甲氧西林金黄色葡萄球菌(MRSA)和粪肠球菌,其最低抑菌浓度(MIC)在0.006至约0.1微克/毫升的浓度范围内。针对枯草芽孢杆菌NRRL B - 558的噻唑基肽抗性突变体的抗菌活性结果表明,MJ347 - 81F4组分A可能的分子靶点是核糖体的50S亚基,其失活会抑制蛋白质合成。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验